Nasdaq review28 Feb 2020 08:26
Novacyt said it had signed its first major distribution agreement for the COVID-19 coronavirus test with a global life sciences company to supply the test to two Asian territories outside mainland China.
It added that initial sales from this, which are subject to local emergency use approval, were anticipated to total 2.1 million pounds ($2.73 million) in the first six months of the agreement.
Novacyt also announced a manufacturing deal with an unnamed U.S. healthcare company.